Sign In
Buy CDXC
$7.87
+0 (+0%)
At Close: Jun 17, 2025
ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
08:34am, Thursday, 23'rd May 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy-aging research, today announced that its
ChromaDex's Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
08:32am, Wednesday, 22'nd May 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, is proud to announce
ChromaDex Corporation (CDXC) Q1 2024 Earnings Call Transcript
08:26pm, Wednesday, 08'th May 2024
ChromaDex Corporation (NASDAQ:CDXC ) Q1 2024 Results Conference Call May 8, 2024 4:30 PM ET Company Participants Ben Shamsian - IR Rob Fried - CEO Brianna Gerber - CFO Andrew Shao - SVP, Scientific an
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces an ingredi
ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
08:34am, Thursday, 25'th Apr 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces that its f
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
08:34am, Wednesday, 24'th Apr 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announced that it will ho
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
08:32am, Tuesday, 23'rd Apr 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces that its flagsh
ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
08:32am, Tuesday, 26'th Mar 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces that its flagsh
ChromaDex Corporation (CDXC) Q4 2023 Earnings Call Transcript
11:11pm, Wednesday, 06'th Mar 2024
ChromaDex Corporation (NASDAQ:CDXC ) Q4 2023 Earnings Conference Call March 6, 2024 4:30 PM ET Company Participants Kendall Knysch - Director, Media Relations Rob Fried - CEO Brianna Gerber - CFO Andr
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
04:04pm, Wednesday, 06'th Mar 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2023 financial results. Fourth Quarter 2023 and Recent Highlights Total
ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024
08:32am, Wednesday, 21'st Feb 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC) (“the Company”), a global bioscience company dedicated to healthy aging, announced that it will hold a conference c
ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow on Monday, February 12, 2024
08:32am, Monday, 05'th Feb 2024
LOS ANGELES--(BUSINESS WIRE)-- #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announced today that it will be p
ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference
04:08pm, Friday, 26'th Jan 2024
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #IR--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today announced that its Chief E
ChromaDex: Growth At A Reasonable Price
07:28pm, Tuesday, 23'rd Jan 2024
Nutraceuticals and supplements industry is gaining traction due to increasing demand for products that promote well-being. ChromaDex Corporation offers an interesting technology and product, Niagen, w
ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®
09:04am, Wednesday, 20'th Dec 2023
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, is proud to announce its
